Working… Menu
Trial record 1 of 1 for:    NCT03470545
Previous Study | Return to List | Next Study

Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03470545
Recruitment Status : Completed
First Posted : March 20, 2018
Last Update Posted : November 17, 2020
Information provided by (Responsible Party):
MyoKardia, Inc.

Results Submitted - Quality Control (QC) Review Has Not Concluded
Results information for an applicable clinical trial (ACT) is posted within 30 days of submission even if the submission has not completed the Results Quality Control (QC) review process. Results information is submitted to by the sponsor or investigator, and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

All versions of ACT results information submissions that have not completed the QC review process are posted on (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.

Recruitment Status : Completed
Actual Primary Completion Date : March 14, 2020
Actual Study Completion Date : May 6, 2020
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 May 7, 2021
June 1, 2021 Submission with QC Comments
2 August 10, 2021
September 3, 2021 Submission with QC Comments
3 September 7, 2021
Publications automatically indexed to this study by Identifier (NCT Number):